Indications for Dialysis in CKD with Anemia
Anemia itself is NOT an indication for dialysis initiation in CKD patients; dialysis should be initiated based on uremic symptoms, volume overload, refractory metabolic derangements, or declining GFR (typically 5-10 mL/min/1.73m²), while anemia should be managed medically with iron supplementation and erythropoiesis-stimulating agents (ESAs) regardless of dialysis status. 1
Understanding the Distinction
The presence of anemia in CKD does not trigger dialysis initiation. These are separate clinical issues that require independent management:
Anemia Management (Pre-Dialysis)
- Initiate ESA therapy when hemoglobin is sustained below 100 g/L (10 g/dL) after correcting iron stores and treating reversible causes 2
- Target hemoglobin: 110 g/L (11 g/dL), acceptable range 100-120 g/L 2
- Ensure adequate iron stores first: TSAT >20% and ferritin >100 ng/mL 3
- IV iron is preferred over oral iron for hemodialysis patients and may be appropriate for some non-dialysis CKD patients 3
Actual Dialysis Indications
Initiate dialysis based on composite assessment including: 1
Uremic symptoms:
- Pericarditis
- Encephalopathy
- Intractable nausea/vomiting
- Bleeding diathesis
- Pruritus refractory to medical management
Volume overload or hypertension:
- Refractory to diuretics and antihypertensives
- Pulmonary edema
- Note: Patients initiating dialysis for volume overload have 1.69 times higher mortality risk compared to those starting for laboratory decline 4
Metabolic derangements:
- Refractory hyperkalemia (>6.5 mEq/L despite medical management)
- Severe metabolic acidosis (pH <7.2 or bicarbonate <10 mEq/L)
GFR considerations:
Nutritional decline:
- Progressive weight loss
- Serum albumin <4.0 g/dL
- Serum transferrin <200 mg/dL
- Spontaneous protein intake <0.8 g/kg/day 6
Pediatric-specific indication:
- Poor growth refractory to optimized nutrition, growth hormone, and medical management 1
Critical Clinical Pitfalls
Avoid early dialysis initiation (eGFR >10 mL/min/1.73m²): The IDEAL study demonstrated no mortality or morbidity benefit from early initiation 5. Early start may actually be associated with higher mortality 7.
Do not confuse anemia severity with dialysis urgency: Severe anemia (hemoglobin <7-8 g/dL) warrants aggressive medical management with IV iron and ESAs, not automatic dialysis initiation 3, 2. Untreated anemia increases morbidity and mortality through cardiac complications, but this is addressed through anemia-specific therapy 3.
Recognize that volume overload as primary indication carries worse prognosis: If initiating dialysis primarily for fluid management, ensure aggressive optimization of diuretics and dietary sodium restriction first, as this indication is associated with 69% higher mortality risk 4.
Practical Algorithm
Assess anemia separately:
- Check iron studies (TSAT, ferritin)
- Correct iron deficiency with IV iron
- Initiate ESA if hemoglobin <10 g/dL after iron repletion
Evaluate for dialysis indications:
- Screen for uremic symptoms at every visit when GFR <15 mL/min/1.73m²
- Monitor for refractory volume overload or hyperkalemia
- Assess nutritional status (albumin, weight trends)
- Calculate kidney failure risk when GFR <20 mL/min/1.73m² 1
Timing decision:
- If symptomatic: initiate dialysis regardless of GFR
- If asymptomatic with GFR 5-10: shared decision-making with patient
- If asymptomatic with GFR >10: continue conservative management
- Plan access placement when GFR <15-20 mL/min/1.73m² 1
The key principle: Treat anemia medically at any CKD stage; reserve dialysis for uremic complications, not anemia itself.